Hall Steven Edward 4
4 · Kymera Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Hall Steven Edward
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+20,063→ 20,063 totalExercise: $49.10Exp: 2031-06-15→ Common Stock (20,063 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.